FDA CLARIFIES ON BASMATI STOCK

  1. Home
  2. Politics
  3. FDA CLARIFIES ON BASMATI STOCK

The Directorate of Food & Drugs Administration has clarified that out of the 04 batches tested in the Referral Laboratory only 02 batches were reported as non compliant to the standards under the Food Safety and Standards Act 2006.

The samples were tested in June 2021 and subsequently the company has withdrawn all the stock from the local market and hence no stock with the below mentioned batch number is available in the market. The matter is under further investigation as per the provisions of the FSSA 2006.

FDA has informed that No Stock containing the batch numbers Daawat Traditional Basmati Rice with batch No. (A1 60017014) and Daawat Pulav Basmati Rice with batch No. (A1 60016202) is available in the open market.

Previous Post
GOA LEGISLATORS’ DAY ON JAN 9
Next Post
DGFT opens COVID 19 help desk to support International Trade during pandemic surge
Menu